• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    7.73 Up 0.75(10.74%) Aug 28, 4:00PM EDT
    |After Hours : 7.75 Up 0.02 (0.26%) Aug 28, 7:33PM EDT
    Add to Portfolio
    Prev Close:6.98
    Open:7.37
    Bid:7.74 x 200
    Ask:7.99 x 100
    1y Target Est:21.40
    Beta:3.30927
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:7.30 - 7.74
    52wk Range:6.19 - 13.04
    Volume:2,638,007
    Avg Vol (3m):1,497,280
    Market Cap:557.46M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INOUp 10.74%557.46M
    PFEDown 1.80%201.43B
    AZNUp 0.19%80.06B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):34.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.57
    Quarterly EPS Est (Sep-15) :-0.04
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback